BioOutsource Ltd., part of Sartorius Stedim Biotech Group and a provider of biologics contract testing and biosimilar characterization for the biopharmaceutical industry, has opened a new facility that doubles its capacity for future growth. “Our opening of this new, state-of-the-art facility demonstrates our commitment to our growing list of global customers,” said Gerry MacKay, chief executive officer, BioOutsource. “Demand for our services remains high and we are doubling our capacity to m...